Research

Molecular

Obesity-related vasodilator dysfunction involves factors such as vascular insulin resistance, lipotoxicity, and visceral adipose tissue expansion.

Understanding these factors can guide targeted interventions for managing obesity-related vascular issues.

StrongSupportsmedium confidence
We will briefly enumerate those recognized causative factors of obesity-related vasodilator dysfunction, such as vascular insulin resistance, lipotoxicity, visceral adipose tissue expansion, and perivascular adipose tissue abnormalities.
Francesca Schinzari et al. · Journal of Cardiovascular Pharmacology · 2021

Why this rating

The claim is based on established knowledge in the field.

Source

Vasodilator Dysfunction in Human Obesity: Established and Emerging Mechanisms

Francesca Schinzari et al. · Journal of Cardiovascular Pharmacology · 2021

reviewCited 4×
Read the paper

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →